Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novo does another small deal, this time with drug delivery biotech Nanexa

The many Novo investors hoping for a transformative deal will have to content themselves with another small development pact. The Swedish biotech Nanexa said Thursday that it has licensed its long-acting ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 25 September →